© 1999 by European Society of Cardiology
Copyright © 1999, European Society of Cardiology
Modulation of constitutive nitric oxide synthase, bcl-2 and Fas expression in cultured human coronary endothelial cells exposed to anoxia–reoxygenation and angiotensin II: role of AT1 receptor activation
Departments of Medicine, Physiology, Pediatrics and Pathology, University of Florida and VA Medical Center, 1600 Archer Rd., P.O. Box 100277, JHMHC Gainesville, FL 32610, USA
* Corresponding author. Tel.: +1-(352)-379-4160; fax: +1-(352)-379-4161; e-mail: mehta@medmac.ufl.edu
Background: Angiotensin II (Ang II) plays a critical role in the pathophysiology of myocardial ischemia–reperfusion injury. We have recently shown that reoxygenation following a period of anoxia causes apoptosis of cultured human coronary artery endothelial cells (HCAECs). Ang II further enhances apoptosis of HCAECs via Ang II type 1 receptor (AT1R) activation. Recent studies suggest an important role of constitutive nitric oxide synthase (cNOS), Fas and bcl-2 proteins in apoptosis. This study was designed to examine the modulation of cNOS, and Fas and bcl-2 expression in HCAECs during exposure to anoxia–reoxygenation and Ang II. Methods and Results: HCAECs were exposed to anoxia–reoxygenation and Ang II. Anoxia- reoxygenation significantly decreased cNOS mRNA, protein and activity in cultured HCAECs (P<0.05 vs. control). Anoxia–reoxygenation also caused an increase in Fas and a decrease in bcl-2 protein expression in cultured HCAECs (both P<0.05 vs. control). The presence of Ang II (0.3 µM) further enhanced these effects of anoxia–reoxygenation on cNOS, Fas and bcl-2 expression. The effects of Ang II were significantly attenuated by the AT1R inhibitor losartan (10 µM). Conclusion: During exposure of HCAECs to anoxia–reoxygenation and Ang II, AT1R activation induces important changes in cNOS mRNA, protein expression and activity, as well as bcl-2 and Fas protein expression which may have a bearing on the development of apoptosis.
KEYWORDS Ang II, Angiotensin II; AT1R, Angiotensin II type 1 receptor; AT2R, Angiotensin II type 2 receptor; cNOS, Constitutive nitric oxide synthase; HCAECs, Human coronary artery endothelial cells; iNOS, Inducible nitric oxide synthase
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. E. Campian, H. J. Verberne, M. Hardziyenka, K. de Bruin, M. Selwaness, M. J.B. van den Hoff, J. M. Ruijter, B. L.F. van Eck-Smit, J. M.T. de Bakker, and H. L. Tan Serial Noninvasive Assessment of Apoptosis During Right Ventricular Disease Progression in Rats J. Nucl. Med., August 1, 2009; 50(8): 1371 - 1377. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. H. Ng, S. Wan, and A. P. C. Yim Pulmonary ischaemia-reperfusion injury: role of apoptosis Eur. Respir. J., February 1, 2005; 25(2): 356 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Attia, O. Feron, R. Goldschmeding, L. H. Radermakers, N. D. Vaziri, P. Boer, J.-L. Balligand, H. A. Koomans, and J. A. Joles Hypercholesterolemia in Rats Induces Podocyte Stress and Decreases Renal Cortical Nitric Oxide Synthesis via an Angiotensin II Type 1 Receptor-Sensitive Mechanism J. Am. Soc. Nephrol., April 1, 2004; 15(4): 949 - 957. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Liu, A. Wallmon, C. Olsson-Mortlock, R. Wallin, and T. Saldeen Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms Am. J. Clinical Nutrition, March 1, 2003; 77(3): 700 - 706. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Li and R. M. Jackson Reactive species mechanisms of cellular hypoxia-reoxygenation injury Am J Physiol Cell Physiol, February 1, 2002; 282(2): C227 - C241. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chen, D. Li, T. Saldeen, and J. L. Mehta TGF-{beta}1 modulates NOS expression and phosphorylation of Akt/PKB in rat myocytes exposed to hypoxia-reoxygenation Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1035 - H1039. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Yang, L. Graham, S. Dikalov, R. P. Mason, J. R. Falck, J. K. Liao, and D. C. Zeldin Overexpression of Cytochrome P450 CYP2J2 Protects against Hypoxia-Reoxygenation Injury in Cultured Bovine Aortic Endothelial Cells Mol. Pharmacol., August 1, 2001; 60(2): 310 - 320. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Neri Serneri, M. Boddi, L. Poggesi, I. Simonetti, M. Coppo, M. L. Papa, G. F. Lisi, M. Maccherini, R. Becherini, A. Boncompagni, et al. Activation of cardiac renin-angiotensin system in unstable angina J. Am. Coll. Cardiol., July 1, 2001; 38(1): 49 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Li, T. Saldeen, F. Romeo, and J. L. Mehta Different Isoforms of Tocopherols Enhance Nitric Oxide Synthase Phosphorylation and Inhibit Human Platelet Aggregation and Lipid Peroxidation: Implications in Therapy with Vitamin E Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2001; 6(2): 155 - 161. [Abstract] [PDF] |
||||
![]() |
R. C. Tambascia, P. M. Fonseca, P. D. C. Corat, H. Moreno Jr, M. J. A. Saad, and K. G. Franchini Expression and Distribution of NOS1 and NOS3 in the Myocardium of Angiotensin II-Infused Rats Hypertension, June 1, 2001; 37(6): 1423 - 1428. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Dalla Libera, B. Ravara, A. Angelini, K. Rossini, M. Sandri, G. Thiene, G. Battista Ambrosio, and G. Vescovo Beneficial Effects on Skeletal Muscle of the Angiotensin II Type 1 Receptor Blocker Irbesartan in Experimental Heart Failure Circulation, May 1, 2001; 103(17): 2195 - 2200. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chen, Y. C. Zhang, D. Li, M. I. Phillips, P. Mehta, M. Shi, and J. L. Mehta Protection against Myocardial Dysfunction Induced by Global Ischemia-Reperfusion by Antisense-Oligodeoxynucleotides Directed at beta 1-Adrenoceptor mRNA J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 722 - 727. [Abstract] [Full Text] |
||||
![]() |
D. Li, B. Yang, and J. L. Mehta Tumor necrosis factor-{alpha} enhances hypoxia-reoxygenation-mediated apoptosis in cultured human coronary artery endothelial cells: critical role of protein kinase C Cardiovasc Res, June 1, 1999; 42(3): 805 - 813. [Abstract] [Full Text] [PDF] |
||||












